00000nam 2200000za 4500 9.847520 CaOODSP 20221107153448 cr ||||||||||| 171121s2018 onca o f000 0 eng d 9780660239385 9780660239392 CaOODSP eng n-cn--- NR16-173/2017E-PDF National Research Council Canada. AMVAD adjuvant for mucosal vaccines (L-11561) [electronic resource]. [Ottawa] : National Research Council Canada, [2018] [2] p. : ill. Issued also in French under title: Adjuvant AMVAD pour vaccins muqueux (L-11561). Caption title. "January 2017." “The NRC has developed a novel archaeal polar lipid mucosal vaccine adjuvant and delivery (AMVAD) platform capable of generating mucosal and systemic immune responses against a wide range of pathogens that infect mucosal surfaces or use them to gain entry to the body”--Highlights, p. [1]. Issued also in print format. Immunological adjuvants Liposomes Adjuvant AMVAD pour vaccins muqueux (L-11561) (CaOODSP)9.847522 AMVAD adjuvant for mucosal vaccines (CaOODSP)9.847521 PDF 166 KB https://publications.gc.ca/collections/collection_2018/cnrc-nrc/NR16-173-2017-eng.pdf